A Win For NexImmune Inc.
Fri, Mar 25, 2022 at 05:30 PM
NexImmune Inc. (NEXI:NASDAQ) rocketted at $4.26, representing a gain of 23.1%. On Thu, Mar 24, 2022, NEXI:NASDAQ hit a New 2-Week High of $3.46. The stock appeared on our News Catalysts scanner on Thu, Mar 17, 2022 at 08:02 AM in the 'PATNERSHIP' category. From Fri, Mar 11, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days
About NexImmune Inc. (NEXI:NASDAQ)
NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology.
Top 10 Gainers:
- Clever Leaves Holdings Inc. (CLVR:NASDAQ), 143.04%
- Forge Global Holdings Inc. (FRGE:NYSE), 50.2%
- Fresh Vine Wine Inc. (VINE:NYSEMKT), 33.65%
- NextDecade Corporation (NEXT:NASDAQ), 32.22%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 25.95%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 25.54%
- NexImmune Inc. (NEXI:NASDAQ), 23.12%
- Tilray, Inc. (TLRY:NASDAQ), 22.81%
- Rockwell Medical, Inc. (RMTI:NASDAQ), 22.63%
- Kidpik Corp. (PIK:NASDAQ), 22.54%